The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been ...

These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

This not only is a high recognition of Roche Diagnostics' innovative strength but also motivates us to further create sustainable value for patients through a new model and through an 'in China ...

Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

WHO approves first mpox diagnostic test for emergency ... treat patients with multiple sclerosis. Stories on US FDA approving injectable Roche multiple sclerosis therapy are withdrawn September ...